ORATEC SPINECATH INTRADISCAL CATHETER

K974464 · Oratec Interventions, Inc. · GEI · Mar 19, 1998 · General, Plastic Surgery

Device Facts

Record IDK974464
Device NameORATEC SPINECATH INTRADISCAL CATHETER
ApplicantOratec Interventions, Inc.
Product CodeGEI · General, Plastic Surgery
Decision DateMar 19, 1998
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4400
Device ClassClass 2
AttributesTherapeutic

Intended Use

The SpineCATH Intradiscal Catheter is intended for use for the coagulation and decompression of disc material to treat symptomatic patients with annular disruption of contained herniated discs.

Device Story

SpineCATH Intradiscal Catheter is a single-use electrothermal device; features flexible shaft with fully insulated body and thermally activated tip. Device includes integrated thermocouple at tip for temperature monitoring. Used exclusively with Oratec generator. Physician inserts catheter into intervertebral disc; generator delivers thermal energy to tip to coagulate and decompress disc material. Intended to treat symptomatic patients with annular disruption of contained herniated discs. Benefits include minimally invasive decompression of disc tissue.

Clinical Evidence

No clinical data provided. Substantial equivalence based on design and intended use comparison to predicate devices.

Technological Characteristics

Single-use electrothermal catheter; flexible shaft; fully insulated shaft; thermally activated tip; integrated thermocouple for temperature monitoring; requires external Oratec generator; biocompatibility per ISO 10993 for limited contact, external communicating, tissue/bone/dentin communicating devices.

Indications for Use

Indicated for symptomatic patients with annular disruption of contained herniated discs requiring coagulation and decompression of disc material.

Regulatory Classification

Identification

An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} K974464 510(k) Premarket Notification Submission Oratec SpineCATH Intradiscal Catheter MAR 19 1998 # 510(k) Summary of Safety and Effectiveness # SpineCATH Intradiscal Catheter This 510(k) safety and effectiveness summary is being submitted in accordance with the requirements of Safe Medical Devices Act 1990 and 21 CFR §807.92. ## General Information | Manufacturer: | Oratec Interventions, Inc. 3700 Haven Court Menlo Park, CA 94025 Phone: (650) 369-9904 | | --- | --- | | Contact Person: | Michael Kwan, Ph.D. Oratec Interventions, Inc. | | Date Prepared: | December 1, 1997 | ## Device Information | Classification: | Class II | | --- | --- | | Trade Name: | SpineCATH Intradiscal Catheter | | Classification Name: | Electrosurgical Device and Accessories (878.4400) | ## Intended Use The SpineCATH Intradiscal Catheter is intended for use for the coagulation and decompression of disc material to treat symptomatic patients with annular disruption of contained herniated discs. ## Product Description The SpineCATH Intradiscal Catheter is a single use electrothermal device utilizing a flexible shaft design and thermally activated tip. The entire length of the shaft is fully insulated and when activated, only the tip delivers thermal energy. In addition, a thermocouple is located at the tip of the catheter to monitor temperature. The SpineCATH Intradiscal Catheter is for use only with the Oratec generator. ## Substantial Equivalence The SpineCATH Intradiscal Catheter is substantially equivalent in design to the Oratec EndoTAC Monopolar Cautery Probe (K972358). The intended use of the SpineCATH Intradiscal Catheter, decompression of intervertebral discs, is substantially equivalent to currently available mechanical and laser devices, 2-2 {1} 510(k) Premarket Notification Submission Oratec SpineCATH Intradiscal Catheter including Surgical Dynamics’ Nucleotomes (K931109, K942987) and Laserscope’s KTP/532 and KTP/YAG Laser Systems (K896183, K913758). ## Biocompatibility The SpineCATH Intradiscal Catheter meets the requirements of ISO 10993 for Limited Contact, External Communicating Devices, Tissue/Bone/Dentin Communicating. ## Summary Based upon the information described in this submission, the Oratec SpineCATH Intradiscal Catheter has been shown to be substantially equivalent to the Oratec EndoTAC Monopolar Cautery Probe, Surgical Dynamics’ Nucleotomes and Laserscope’s KTP/532 and KTP/YAG Laser Systems. Michael Kwan Oratec Interventions, Inc. November 26, 1997 2-3 {2} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAR 19 1998 Dr. Michael Kwan Oratec Interventions, Incorporated 3700 Haven Court Menlo Park, California 94025 Re: K974464 Trade Name: Oratec SpineCATH Intradiscal Catheter Regulatory Class: II Product Code: GEI Dated: February 4, 1998 Received: February 5, 1998 Dear Dr. Kwan: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3} Page 2 - Dr. Kwan This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for *in vitro* diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, ![img-0.jpeg](img-0.jpeg) Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4} Page 1 of 1 510(k) Number (if known): 974464 Device Name: Oratec SpineCATH Intradiscal Catheter Indications For Use: The Oratec SpineCATH Intradiscal Catheter is intended for use for the coagulation and decompression of disc material to treat symptomatic patients with annular disruption of contained herniated discs. PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE (IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Stephen Pluode (Division Sign-Off) Division of General Restorative Devices 510(k) Number K974464 Prescription Use ☑ (Per 21 CFR 801.109) OR Over-The-Counter Use ☐ (Optional Format 1-2-96)
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%